Dual role of the adaptor protein SLP-65: Organizer of signal transduction and tumor suppressor of pre-B cell leukemia

Immunologic Research

Volumn 34, Issue 2, 2006, Pages 143-155

  Herzog, Sebastian ^a   Storch, Bettina ^a   Jumaa, Hassan ^a  

^a MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

Author keywords

B cell development; Btk; Leukemia; SLP 65; Tumor suppressor

Indexed keywords

ADAPTOR PROTEIN; B LYMPHOCYTE RECEPTOR; PROTEIN SLP65; UNCLASSIFIED DRUG;

B CELL LEUKEMIA; CANCER INHIBITION; CELL PROLIFERATION; NONHUMAN; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; B-LYMPHOCYTES; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; LEUKEMIA, PRE-B-CELL; MEMBRANE GLYCOPROTEINS; PHOSPHOPROTEINS; PROTEIN-TYROSINE KINASES; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 33745683797     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:34:2:143     Document Type: Review

References (71)

1. Bradl H, Jack HM: Surrogate light chain-mediated interaction of a soluble pre-B cell receptor with adherent cell lines. J Immunol 2001; 167 (11): 6403-6411.
2. Gauthier L, Rossi B, Roux F, Termine E, Schiff C: Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci USA 2002; 99 (20): 13014-13019.
3. Karasuyama H, Rolink A, Melchers F: Surrogate light chain in B cell development. Adv Immunol 1996; 63: 1-41.
4. Kitamura D, Roes J, Kuhn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991; 350 (6317): 423-426.
5. Macpherson AJ, Lamarre A, McCoy K, et al: IgA production without mu or delta chain expression in developing B cells. Nat Immunol 2001; 2 (7): 625-631.
6. Kitamura D, Kudo A, Schaal S, Muller W, Melchers F, Rajewsky K: A critical role of lambda 5 protein in B cell development. Cell 1992; 69 (5): 823-831.
7. Martensson A, Argon Y, Melchers F, Dul JL, Martensson IL: Partial block in B lymphocyte development at the transition into the pre-B cell receptor stage in Vpre-B1-deficient mice. Int Immunol 1999; 11 (3): 453-460.
8. Mundt C, Licence S, Shimizu T, Melchers F, Martensson IL: Loss of precursor B cell expansion but not allelic exclusion in VpreB1/VpreB2 double-deficient mice. J Exp Med 2001; 193 (4): 435-445.
9. Gong S, Nussenzweig MC: Regulation of an early developmental checkpoint in the B cell pathway by Ig beta. Science 1996; 272 (5260): 411-414.
10. Pelanda R, Braun U, Hobeika E, Nussenzweig MC, Reth M: B cell progenitors are arrested in maturation but have intact VDJ recombination in the absence of Ig-alpha and Ig-beta. J Immunol 2002; 169 (2): 865-872.
11. Hombach J, Tsubata T, Leclercq L, Stappert H, Reth M: Molecular components of the B-cell antigen receptor complex of the IgM class. Nature 1990; 343 (6260): 760-762.
12. Turner M, Mee PJ, Costello PS, et al: Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995; 378 (6554): 298-302.
13. Hayashi K, Nittono R, Okamoto N, et al: The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells. Proc Natl Acad Sci USA 2000; 97 (6): 2755-2760.
14. Jumaa H, Wollscheid B, Mitterer M, Wienands J, Reth M, Nielsen PJ: Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 1999; 11 (5): 547-554.
15. Khan WN, Alt FW, Gerstein RM, et al: Defective B cell development and function in Btk-deficient mice. Immunity 1995; 3 (3): 283-299.
16. Pappu R, Cheng AM, Li B, et al: Requirement for B cell linker protein (BLNK) in B cell development. Science 1999; 286 (5446): 1949-1954.
17. Wang D, Feng J, Wen R, et al: Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity 2000; 13 (1): 25-35.
18. Xu S, Tan JE, Wong EP, Manickam A, Ponniah S, Lam KP: B cell development and activation defects resulting in xid-like immunodeficiency in BLNK/SLP-65-deficient mice. Int Immunol 2000; 12 (3): 397-404.
19. Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ: Engagement of the human pre-B cell receptor generates a lipid raft-dependent calcium signaling complex. Immunity 2000; 13 (2): 243-253.
20. Rolink AG, Winkler T, Melchers F, Andersson J: Precursor B cell receptor-dependent B cell proliferation and differentiation does not require the bone marrow or fetal liver environment. J Exp Med 2000; 191 (1): 23-32.
21. Bannish G, Fuentes-Panana EM, Cambier JC, Pear WS, Monroe JG: Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J Exp Med 2001; 194 (11): 1583-1596.
22. Cheng PC, Dykstra ML, Mitchell RN, Pierce SK: A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 1999; 190 (11): 1549-1560.
23. Rolli V, Gallwitz M, Wossning T, et al: Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop. Mol Cell 2002; 10 (5): 1057-1069.
24. Futterer K, Wong J, Grucza RA, Chan AC, Waksman G: Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. J Mol Biol 1998; 281 (3): 523-537.
25. Kurosaki T, Johnson SA, Pao L, Sada K, Yamamura H, Cambier JC: Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J Exp Med 1995; 182 (6): 1815-1823.
26. Chiu CW, Dalton M, Ishiai M, Kurosaki T, Chan AC: BLNK: molecular scaffolding through "cis"-mediated organization of signaling proteins. EMBO J 2002; 21 (23): 6461-6472.
27. Baba Y, Hashimoto S, Matsushita M, et al: BLNK mediates Syk-dependent Btk activation. Proc Nalt Acad Sci USA 2001; 98 (5): 2582-2586.
28. Fluckiger A-C, Li Z, Kato RM, et al: Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J 1998; 17 (7): 1973-1985.
29. Hashimoto A, Okada H, Jiang A, et al: Involvement of guanosine triphosphatases and phospholipase C-gamma2 in extracellular signal-regulated kinase, c-Jun NH2-terminal kinase, and p38 mitogen-activated protein kinase activation by the B cell antigen receptor. J Exp Med 1998; 188 (7): 1287-1295.
30. Jiang A, Craxton A, Kurosaki T, Clark EA: Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase. J Exp Med 1998; 188 (7): 1297-1306.
31. Johmura S, oh-hora M, Inabe K, et al: Regulation of Vav localization in membrane rafts by adaptor molecules Grb2 and BLNK. Immunity 2003; 18 (6): 777-787.
32. Wienands J, Schweikert I, Wollscheid B, Jumaa H, Nielsen PJ, Reth M: SLP-65: a new signaling component in B lymphocytes which requires expression of the antigen receptor for phosphorylation. J Exp Med 1998; 188 (4): 791-795.
33. Rodriguez-Viciana P, Warne PH, Vanhaesebroeck B, Waterfield MD, Downward J: Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J 1996; 15 (10): 2442-2451.
34. Vojtek AB, Hollenberg SM, Cooper JA: Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 1993; 74 (1): 205-214.
35. Nagaoka H, [???] et al: Ras mediates effector pathways responsible for pre-B cell survival, which is essential for the developmental progression to the late pre-B cell stage. J Exp Med 2000; 192 (2): 171-182.
36. Shaw AC, Swat W, Davidson L, Alt FW: Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras. Proc Natl Acad Sci USA 1999; 96 (5): 2239-2243.
37. Ishiai M, Kurosaki M, Pappu R, et al: BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells. Immunity 1999; 10 (1): 117-125.
38. Tan JE, Wong SC, Gan SK, Xu S, Lam KP: The adaptor protein BLNK is required for b cell antigen receptor-induced activation of nuclear factor-kappa B and cell cycle entry and survival of B lymphocytes. J Biol Chem 2001; 276 (23): 20055-20063.
39. Flemming A, Brummer T, Reth M, Jumaa H: The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol 2003; 4 (1): 38-43.
40. Rolink A, Kudo A, Karasuyama H, Kikuchi Y, Melchers F: Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J 1991; 10 (2): 327-336.
41. Jumaa H, Bossaller L, Portugal K, et al: Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature 2003; 423 (6938): 452-456.
42. Goodman PA, Wood CM, Vassilev A, Mao C, Uckun FM: Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia. Oncogene 2001; 20 (30): 3969-3978.
43. Jumaa H, Mitterer M, Reth M, Nielsen PJ: The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. Eur J Immunol 2001; 31 (7): 2164-2169.
44. Kersseboom R, Middendorp S, Dingjan GM, et al: Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells. J Exp Med 2003; 198 (1): 91-98.
45. Middendorp S, Dingjan GM, Maas A, Dahlenborg K, Hendriks RW: Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity. J Immunol 2003; 171 (11): 5988-5996.
46. Saito K, Tolias KF, Saci A, et al: BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity 2003; 19 (5): 669-678.
47. Scharenberg AM, El-Hillal O, Fruman DA, et al: Phosphatidylinositol-3,4, 5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J 1998; 17 (7): 1961-1972.
48. Ishiai M, Kurosaki M, Inabe K, Chan AC, Sugamura K, Kurosaki T: Involvement of LAT, Gads, and Grb2 in compartmentation of SLP-76 to the plasma membrane. J Exp Med 2000; 192 (6): 847-856.
49. Su YW, Jumaa H: LAT links the pre-BCR to calcium signaling. Immunity 2003; 19 (2): 295-305.
50. Brdicka T, Imrich M, Angelisova P, et al: Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. J Exp Med 2002; 196 (12): 1617-1626.
51. Janssen E, Zhu M, Zhang W, Koonpaew S: LAB: a new membrane-associated adaptor molecule in B cell activation. Nat Immunol 2003; 4 (2): 117-123.
52. Gold MR, Crowley MT, Martin GA, McCormick F, DeFranco AL: Targets of B lymphocyte antigen receptor signal transduction include the p21ras GTPase-activating protein (GAP) and two GAP-associated proteins. J Immunol 1993; 150 (2): 377-386.
53. Ellis C, Moran M, McCormick F, Pawson T: Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases. Nature 1990; 343 (6256): 377-381.
54. Di Cristofano A, Niki M, Zhao M, et al: p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med 2001; 194 (3): 275-284.
55. Yoshida K, Yamashita Y, Miyazato A, et al: Mediation by the protein-tyrosine kinase Tec of signaling between the B cell antigen receptor and Dok-1. J Biol Chem 2000; 275 (32): 24945-24952.
56. Kitanaka A, Mano H, Conley ME, Campana D: Expression and activation of the nonreceptor tyrosine kinase Tec in human B cells. Blood 1998; 91 (3): 940-948.
57. Sherr CJ: Principles of tumor suppression. Cell 2004; 116 (2): 235-246.
58. Schebesta M, Pfeffer PL, Busslinger M: Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 2002; 17 (4): 473-485.
59. Nakayama K, Ishida N, Shirane M, et al: Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996; 85 (5): 707-720.
60. Li Z, Dordai DI, Lee J, Desiderio S: A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle. Immunity 1996; 5 (6): 575-589.
61. Lin WC, Desiderio S: Cell cycle regulation of V(D)J recombination- activating protein RAG-2. Proc Natl Acad Sci USA 1994; 91 (7): 2733-2737.
62. Mizuta R, Mizuta M, Araki S, Kitamura D: RAG2 is down-regulated by cytoplasmic sequestration and ubiquitin-dependent degradation. J Biol Chem 2002; 277 (44): 41,423-41,427.
63. Lee J, Desiderio S: Cyclin A/CDK2 regulates V(D)J recombination by coordinating RAG-2 accumulation and DNA repair. Immunity 1999; 11 (6): 771-781.
64. Shirane M, Harumiya Y, Ishida N, et al: Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 1999; 274 (20): 13,886-13,893.
65. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, Roberts JM: A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 2001; 413 (6853): 323-327.
66. Pagano M, [???]Tam SW, Theodoras AM, et al: Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269 (5224): 682-685.
67. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1 (4): 193-199.
68. Sutterluty H, Chatelain E, Marti A, et al: p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999; 1 (4): 207-214.
69. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H: p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9 (12): 661-664.
70. Jiang H, Chang FC, Ross AE, Lee J, Nakayama K, Desiderio S: Ubiquitylation of RAG-2 by Skp2-SCF links destruction of the V(D)J recombinase to the cell cycle. Mol Cell 2005; 18 (6): 699-709.
71. Wang W, Ungermannova D, Jin J, Harper JW, Liu X: Negative regulation of SCFSkp2 ubiquitin ligase by TGF-beta signaling. Oncogene 2004; 23 (5): 1064-1075.